ReviewFrontiers in cellular and infection microbiology2026
Gut microbiota as a therapeutic target in sepsis-induced multi-organ dysfunction: a review.
Review in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sepsis and the resulting multiple organ dysfunction carry a high mortality rate, and effective treatment remains lacking owing to the condition's heterogeneity. The translocation of gut microbiota plays an essential role in the occurrence and development of sepsis and organ dysfunction. Uncontrolled inflammatory responses in sepsis, together with antibiotic use during treatment, lead to gut microbiota translocation. This in turn promotes sepsis progression and organ dysfunction by altering microbial metabolite production and causing immune dysregulation. Drawing on literature from databases such as PubMed and Web of Science, this review summarizes the interactions between intestinal microbiota translocation, sepsis, and organ dysfunction, aiming to identify new targets for the prevention and treatment of sepsis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.